Previously approved only for adult patients, REAL-Time Continuous Glucose Monitoring (CGM) devices are now approved for children and teenagers ages 7 to 17. REAL-Time CGM helps patients monitor and better control their diabetes. This therapy is intended to reduce the duration of hypoglycemic events and lower HbA1c levels by as much as two percentage points.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now